|
2022 Journal Article Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM)Keller, Jutta, Wedel, Thilo, Seidl, Holger, Kreis, Martin E., Van Der Voort, Ivo, Gebhard, Maximilian, Langhorst, Jost, Lynen Jansen, Petra, Schwandner, Oliver, Storr, Martin, Van Leeuwen, Pia, Andresen, Viola, Preiβ, Jan C., Layer, Peter, Allescher, H., Andus, T., Bischoff, S. C., Buderus, S., Claβen, M., Ehlert, U., Elsenbruch, S., Engel, M., Enninger, A., Fischbach, W., Freitag, M., Frieling, T., Gillessen, A., Goebel-Stengel, M., Gschossmann, J. ... Von Schönfeld, J. (2022). Updated S3 guideline on intestinal motility disorders: Definition, pathophysiology, diagnosis and treatment. Joint guideline of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021-018 Update S3-Leitlinie Intestinale Motilitätsstörungen: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM). Zeitschrift fur Gastroenterologie, 60 (2), 192-218. doi: 10.1055/a-1646-1279 |
|
2022 Journal Article Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trialPeyrin-Biroulet, Laurent, Hart, Ailsa, Bossuyt, Peter, Long, Millie, Allez, Matthieu, Juillerat, Pascal, Armuzzi, Alessandro, Loftus, Edward V, Ostad-Saffari, Elham, Scalori, Astrid, Oh, Young S, Tole, Swati, Chai, Akiko, Pulley, Jennifer, Lacey, Stuart, Sandborn, William J, Aguilar, Humberto, Ahmad, Tariq, Akriviadis, Evangelos, Aldeguer Mante, Xavier, Altorjay, Istvan, Ananthakrishnan, Ashwin, Andersen, Vibeke, Andreu Garcia, Montserrat, Aumais, Guy, Avni-Biron, Irit, Axler, Jeffrey, Ayub, Kamran, Baert, Filip ... Zeuzem, Stefan (2022). Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial. The Lancet Gastroenterology and Hepatology, 7 (2), 128-140. doi: 10.1016/S2468-1253(21)00298-3 |
|
2022 Journal Article Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studiesShah, Ayesha, Fairlie, Thomas, Brown, Georgia, Jones, Michael P., Eslick, Guy D., Duncanson, Kerith, Thapar, Nikhil, Keely, Simon, Koloski, Natasha, Shahi, Mohit, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald (2022). Duodenal eosinophils and mast cells in functional dyspepsia: a systematic review and meta-analysis of case-control studies. Clinical Gastroenterology and Hepatology, 20 (10), 2229-2242.e29. doi: 10.1016/j.cgh.2022.01.014 |
|
2022 Journal Article Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trialsRubin, David T, Dotan, Iris, DuVall, Aaron, Bouhnik, Yoram, Radford-Smith, Graham, Higgins, Peter D R, Mishkin, Daniel S, Arrisi, Pablo, Scalori, Astrid, Oh, Young S, Tole, Swati, Chai, Akiko, Chamberlain-James, Kirsten, Lacey, Stuart, McBride, Jacqueline, Panés, Julian, Abdulkhakov, Rustem, Abu Bakar, Norasiah, Aguilar, Humberto, Aizenberg, Diego, Akpinar, Hale, Akriviadis, Evangelos, Alexeeva, Olga, Alikhanov, Bagdadi, Alvarisqueta, Andres, Ananthakrishnan, Ashwin, Andrews, Jane, Arlukowicz, Tomasz, Atkinson, Nathan ... on behalf of the HIBISCUS Study Group (2022). Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. The Lancet Gastroenterology and Hepatology, 7 (1), 17-27. doi: 10.1016/S2468-1253(21)00338-1 |
|
2022 Journal Article Small intestinal bacterial overgrowth in inflammatory bowel diseaseShah, Ayesha and Holtmann, Gerald (2022). Small intestinal bacterial overgrowth in inflammatory bowel disease. Indian Journal of Gastroenterology, 41 (1), 23-29. doi: 10.1007/s12664-021-01235-y |
|
2021 Journal Article The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaireJones, Michael P., Yun, Grace, Wass, Fiona, Rixon, Hayley, Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald, Talley, Nicholas J. and Beath, Alissa P. (2021). The role of mood state and emotion regulation in the discrepancy between gastrointestinal symptom burden recorded prospectively and via recall questionnaire. Neurogastroenterology and Motility, 34 (7) e14304, 1-8. doi: 10.1111/nmo.14304 |
|
2021 Journal Article Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomesJones, Michael P., Walter, Susanna, Talley, Nicholas J., Walker, Marjorie M., Holtmann, Gerald J., Shah, Ayesha, D'Amato, Mauro, Agréus, Lars and Andreasson, Anna (2021). Clusters of community-dwelling individuals empirically derived from stool diaries correspond with clinically meaningful outcomes. European Journal of Gastroenterology and Hepatology, 33 (S1), e740-e745. doi: 10.1097/MEG.0000000000002236 |
|
2021 Journal Article Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot studyEjova, Anastasia, Badcock, Nicholas A., McKerchar, Sarah, Beath, Alissa P., Swift, Claire, Talley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M. and Jones, Michael P. (2021). Electroencephalographic evidence of unconscious and conscious attentional bias in people with functional gastrointestinal disorders: A pilot study. International Journal of Psychophysiology, 170, 30-42. doi: 10.1016/j.ijpsycho.2021.09.006 |
|
2021 Journal Article S3 guideline update on irritable bowel syndrome: Definition, pathophysiology, diagnosis and treatment. Joint guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021/016 Update S3-leitlinie reizdarmsyndrom: Definition, pathophysiologie, diagnostik und therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für neurogastroenterologie und Motilität (DGNM) Juni 2021 - AWMF-registriernummer: 021/016Layer, Peter, Andresen, Viola, Allescher, H., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel-Stengel, M., Häuser, W., Holtmann, G., Keller, J., Kreis, M. E., Kruis, W., Langhorst, J., Jansen, P. Lynen, Madisch, A., Mönnikes, H., Müller-Lissner, S., Niesler, B., Pehl, C., Pohl, D., Raithel, M., Röhrig-Herzog, G., Schemann, M., Schmiedel, S., Schwille-Kiuntke, J., Storr, M. ... Wedel, T. (2021). S3 guideline update on irritable bowel syndrome: Definition, pathophysiology, diagnosis and treatment. Joint guidelines of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS) and the German Society for Neurogastroenterology and Motility (DGNM). June 2021 - AWMF Register No.: 021/016 Update S3-leitlinie reizdarmsyndrom: Definition, pathophysiologie, diagnostik und therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für neurogastroenterologie und Motilität (DGNM) Juni 2021 - AWMF-registriernummer: 021/016. Zeitschrift fur Gastroenterologie, 59 (12), 1323-1415. doi: 10.1055/a-1591-4794 |
|
2021 Journal Article Autism-related dietary preferences mediate autism-gut microbiome associationsYap, Chloe X., Henders, Anjali K., Alvares, Gail A., Wood, David L.A., Krause, Lutz, Tyson, Gene W., Restuadi, Restuadi, Wallace, Leanne, McLaren, Tiana, Hansell, Narelle K., Cleary, Dominique, Grove, Rachel, Hafekost, Claire, Harun, Alexis, Holdsworth, Helen, Jellett, Rachel, Khan, Feroza, Lawson, Lauren P., Leslie, Jodie, Frenk, Mira Levis, Masi, Anne, Mathew, Nisha E., Muniandy, Melanie, Nothard, Michaela, Miller, Jessica L., Nunn, Lorelle, Holtmann, Gerald, Strike, Lachlan T., de Zubicaray, Greig I. ... Gratten, Jacob (2021). Autism-related dietary preferences mediate autism-gut microbiome associations. Cell, 184 (24), 5916-5931.e17. doi: 10.1016/j.cell.2021.10.015 |
|
2021 Journal Article Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disordersJones, Michael P., Shah, Ayesha, Walker, Marjorie M., Koloski, Natasha A., Holtmann, Gerald and Talley, Nicholas J. (2021). Antibiotic use but not gastrointestinal infection frequently precedes first diagnosis of functional gastrointestinal disorders. United European Gastroenterology Journal, 9 (9), 1074-1080. doi: 10.1002/ueg2.12164 |
|
2021 Journal Article Physician perceptions on the use of antibiotics and probiotics in adults: an international survey in the Asia-Pacific areaGhoshal, Uday C., Gwee, Kok-Ann, Holtmann, Gerald, Li, Yanmei, Park, Soo Jung, Simadibrata, Marcellus, Sugano, Kentaro, Cohen, Henry and Quigley, Eamonn M. M. (2021). Physician perceptions on the use of antibiotics and probiotics in adults: an international survey in the Asia-Pacific area. Frontiers in Cellular and Infection Microbiology, 11 722700, 722700. doi: 10.3389/fcimb.2021.722700 |
|
2021 Journal Article Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissueHoedt, Emily C., Shanahan, Erin R., Keely, Simon, Shah, Ayesha, Burns, Grace L., Holtmann, Gerald J., Talley, Nicholas J. and Morrison, Mark (2021). Draft genome sequence of streptococcus salivarius AGIRA0003, isolated from functional gastrointestinal disorder duodenal tissue. Microbiology Resource Announcements, 10 (39) e00758, e0075821. doi: 10.1128/MRA.00758-21 |
|
2021 Journal Article Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing CholangitisJohnson, Kevin M., Fischer, Ryan T., Holtmann, Gerald J., Shah, Ayesha, Alrabadi, Leina and Lewindon, Peter (2021). Letter to the Editor: Oral Vancomycin Versus No Therapy for Pediatric Primary Sclerosing Cholangitis. Hepatology, 74 (3), 1716-1717. doi: 10.1002/hep.31764 |
|
2021 Journal Article Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 AustraliansKoloski, Natasha A., Jones, Michael, Walker, Marjorie M., Keely, Simon, Holtmann, Gerald and Talley, Nicholas J. (2021). Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians. Alimentary Pharmacology and Therapeutics, 54 (5) apt.16500, 627-636. doi: 10.1111/apt.16500 |
|
2021 Journal Article Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsiaShah, Ayesha, Gurusamy, Saravana Ruban, Hansen, Teressa, Callaghan, Gavin, Talley, Nicholas J., Koloski, Natasha, Walker, Marjorie M., Jones, Michael P., Morrison, Mark and Holtmann, Gerald J. (2021). Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia. Digestive Diseases and Sciences, 67 (6), 2299-2309. doi: 10.1007/s10620-021-07149-1 |
|
2021 Journal Article Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseasesJones, Michael P., Shah, Ayesha, Ben-Jacob, Ronen, Talley, Nicholas J., Hansen, Teressa, Walker, Marjorie M., Gray, Marcus, Koloski, Natasha A. and Holtmann, Gerald (2021). Routine assessment of gastrointestinal symptom using a validated questionnaire in the clinical setting to assess the probability of organic or functional gastrointestinal diseases. Neurogastroenterology and Motility, 33 (8) e14091, e14091. doi: 10.1111/nmo.14091 |
|
2021 Journal Article Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double-blind, placebo-controlled parallel-group trialTalley, N. J., Walker, M. M., Jones, M., Keely, S., Koloski, N., Cameron, R., Fairlie, T., Burns, G., Shah, A., Hansen, T., Harris, G. and Holtmann, G. (2021). Letter: budesonide for functional dyspepsia with duodenal eosinophilia—randomised, double-blind, placebo-controlled parallel-group trial. Alimentary Pharmacology and Therapeutics, 53 (12), 1332-1333. doi: 10.1111/apt.16396 |
|
2021 Journal Article Dyspepsia: Treatment Options Directed to Specific TargetsHoltmann, Gerald, Shah, Ayesha, Jacob, Ronen Ben and Koloski, Natasha (2021). Dyspepsia: Treatment Options Directed to Specific Targets. Current Treatment Options in Gastroenterology, 19 (3), 434-442. doi: 10.1007/s11938-021-00349-8 |
|
2021 Journal Article Patient positioning guidelines for gastrointestinal endoscopic proceduresMeeusen, Vera, Kim, Nick, Elson, Jerome, Ma, Regan, Newman, Fiona, Bendeich, Jess and Holtmann, Gerald (2021). Patient positioning guidelines for gastrointestinal endoscopic procedures. Gastroenterology Nursing, 44 (3), 185-191. doi: 10.1097/SGA.0000000000000534 |
